Semin Liver Dis 2013; 33(03): 236-247
DOI: 10.1055/s-0033-1351779
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnosis and Management of Benign Liver Tumors

Laurence Chiche
1   CHU Bordeaux, Haut-Lévèque Hospital, Department of Digestive Surgery, Pessac, F-33600, France; University of Bordeaux Segalen, Bordeaux, F-33076, France
,
Jean-Philippe Adam
1   CHU Bordeaux, Haut-Lévèque Hospital, Department of Digestive Surgery, Pessac, F-33600, France; University of Bordeaux Segalen, Bordeaux, F-33076, France
› Author Affiliations
Further Information

Publication History

Publication Date:
13 August 2013 (online)

Abstract

The widespread use of imaging modalities and the continuous improvement in their sensitivity have lead to an increasing number of incidental findings of focal liver masses, either solitary or multiple. Most of these so-called incidentalomas are benign and are discovered in healthy, asymptomatic patients. The main issue is to ensure the proper diagnosis, so that clear management recommendations can be provided. Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major role in the cure. Due to better understanding of the clinical and pathological features of benign liver tumors, the increased accuracy of imaging tools, and improvement in surgical techniques (including laparoscopy), the management of these lesions has evolved. Here the clinical and biological features of the most common solid and cystic benign liver tumors are reviewed, and the key points of management focusing on the role of surgery, preventive or diagnostic, are addressed.

 
  • References

  • 1 Rungsinaporn K, Phaisakamas T. Frequency of abnormalities detected by upper abdominal ultrasound. J Med Assoc Thai 2008; 91 (7) 1072-1075
  • 2 Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39 (2) 183-188
  • 3 Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59 (4) 995-1013
  • 4 Saegusa T, Ito K, Oba N , et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995; 34 (3) 207-211
  • 5 Lui W, Zhang S, Hu T, Wei F, Gao Y, Cheng N. Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 1997; 110 (5) 349-351
  • 6 Gemer O, Moscovici O, Ben-Horin CL, Linov L, Peled R, Segal S. Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet Gynecol Scand 2004; 83 (12) 1199-1201
  • 7 Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 2008; 28 (3) 302-314
  • 8 Bioulac-Sage P, Balabaud C, Bedossa P , et al; Laennec and Elves groups. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007; 46 (3) 521-527
  • 9 Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5 (6) 1194-1200
  • 10 Kehagias D, Moulopoulos L, Antoniou A , et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001; 11 (2) 202-212
  • 11 Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23 (12) 1441-1454
  • 12 Vilgrain V, Uzan F, Brancatelli G, Federle MP, Zappa M, Menu Y. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 2003; 229 (1) 75-79
  • 13 World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use. 4th ed. Geneva, Switzerland: WHO ; 2009
  • 14 Bouyn CI, Leclere J, Raimondo G , et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97 (12) 3107-3113
  • 15 Masetti R, Biagi C, Kleinschmidt K , et al. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?. Eur J Pediatr 2011; 170 (6) 807-812
  • 16 Bioulac-Sage P, Rebouissou S, Sa Cunha A , et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128 (5) 1211-1218
  • 17 Federle MP, Brancatelli G. Imaging of benign hepatic masses. Semin Liver Dis 2001; 21 (2) 237-249
  • 18 Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12 (4) 460-465
  • 19 Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11 (5) 787-797
  • 20 Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis 2002; 6 (1) 119-145
  • 21 Stromeyer FW, Ishak KG. Nodular transformation (nodular “regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12 (1) 60-71
  • 22 Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001; 48 (41) 1425-1429
  • 23 Rooks JB, Ory HW, Ishak KG , et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242 (7) 644-648
  • 24 Dokmak S, Paradis V, Vilgrain V , et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137 (5) 1698-1705
  • 25 Søe KL, Søe M, Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992; 12 (2) 73-79
  • 26 Edmondson HA, Reynolds TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977; 86 (2) 180-182
  • 27 Bühler H, Pirovino M, Akobiantz A , et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982; 82 (4) 775-782
  • 28 Parangi S, Levine D, Henry A, Isakovich N, Pories S. Surgical gastrointestinal disorders during pregnancy. Am J Surg 2007; 193 (2) 223-232
  • 29 Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN. Management of hepatocellular adenoma during pregnancy. Liver 2000; 20 (2) 186-187
  • 30 Martin NM, Abu Dayyeh BK, Chung RT. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol 2008; 14 (28) 4573-4575
  • 31 Ronald M, Woodfield J, McCall J, Koea J. Hepatic adenomas in male patients. HPB (Oxford) 2004; 6 (1) 25-27
  • 32 Labrune P, Trioche P, Duvaltier I, Chevalier P, Odièvre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24 (3) 276-279
  • 33 Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J. Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol 2009; 15 (26) 3217-3227
  • 34 Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 2006; 26 (4) 433-438
  • 35 Noels JE, van Aalten SM, van der Windt DJ , et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011; 54 (3) 553-558
  • 36 Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187 (2) 181-191
  • 37 Bioulac-Sage P, Laumonier H, Couchy G , et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50 (2) 481-489
  • 38 Cho SW, Marsh JW, Steel J , et al. Surgical management of hepatocellular adenoma: take it or leave it?. Ann Surg Oncol 2008; 15 (10) 2795-2803
  • 39 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12 (8) 509-522
  • 40 Deneve JL, Pawlik TM, Cunningham S , et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16 (3) 640-648
  • 41 Galanski M, Jördens S, Weidemann J. [Diagnosis and differential diagnosis of benign liver tumors and tumor-like lesions]. Chirurg 2008; 79 (8) 707-721
  • 42 Zucman-Rossi J, Jeannot E, Nhieu JT , et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43 (3) 515-524
  • 43 Bioulac-Sage P, Rebouissou S, Thomas C , et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46 (3) 740-748
  • 44 Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban R, Theise ND, , eds. World Health Organization Classification of Tumours of the Digestive tract. 2nd ed. Lyon, France: IARC; 2010: 198-204
  • 45 Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011; 60 (1) 85-89
  • 46 Paradis V, Champault A, Ronot M , et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46 (1) 140-146
  • 47 Flejou JF, Barge J, Menu Y , et al. Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology 1985; 89 (5) 1132-1138
  • 48 Veteläinen R, Erdogan D, de Graaf W , et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008; 28 (4) 499-508
  • 49 Chiche L, Dao T, Salamé E , et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000; 231 (1) 74-81
  • 50 Chang Z, Zhang JM, Ying JQ, Ge YP. Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions. J Gastrointestin Liver Dis 2011; 20 (1) 65-69
  • 51 Deng YF, Lin Q, Zhang SH, Ling YM, He JK, Chen XF. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract 2008; 204 (12) 911-918
  • 52 Martin-Benitez G, Marti-Bonmati L, Barber C, Vila R. Hepatic lipomas and steatosis: an association beyond chance. Eur J Radiol 2012; 81 (4) e491-e494
  • 53 Itai Y, Saida Y. Pitfalls in liver imaging. Eur Radiol 2002; 12 (5) 1162-1174
  • 54 Cook JR, Pfeifer JD, Dehner LP. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. Hum Pathol 2002; 33 (9) 893-898
  • 55 Chang CS, Lin KC, Hwang SL, Shen CY, Sun MS. Nonparasitic hepatic cysts detected in ultrasonographic examination: analysis of 95 cases. Taiwan Yi Xue Hui Za Zhi 1989; 88 (4) 394-399
  • 56 Larssen TB, Rørvik J, Hoff SR, Horn A, Rosendahl K. The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005; 60 (9) 1026-1029
  • 57 Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003; 58 (8) 626-629
  • 58 Sanchez H, Gagner M, Rossi RL , et al. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991; 161 (1) 113-118 , discussion 118–119
  • 59 Erdogan D, van Delden OM, Rauws EA , et al. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World J Gastroenterol 2007; 13 (22) 3095-3100
  • 60 Takahashi G, Yoshida H, Mamada Y, Taniai N, Bando K, Tajiri T. Journal of Nippon Medical School. Intracystic hemorrhage of a large simple hepatic cyst. J Nippon Med Sch 2008; 75 (5) 302-305
  • 61 Ishikawa H, Uchida S, Yokokura Y , et al. Nonparasitic solitary huge liver cysts causing intracystic hemorrhage or obstructive jaundice. J Hepatobiliary Pancreat Surg 2002; 9 (6) 764-768
  • 62 England RA, Wells IP, Gutteridge CM. Benign external compression of the inferior vena cava associated with thrombus formation. Br J Radiol 2005; 78 (930) 553-557
  • 63 Poggi G, Gatti C, Delmonte A, Teragni C, Bernardo G. Spontaneous rupture of non-parasitic hepatic cyst. Int J Clin Pract 2006; 60 (1) 99-103
  • 64 Klingler PJ, Gadenstätter M, Schmid T, Bodner E, Schwelberger HG. Treatment of hepatic cysts in the era of laparoscopic surgery. Br J Surg 1997; 84 (4) 438-444
  • 65 Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 1986; 30 (1) 29-37
  • 66 Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76 (2) 149-168
  • 67 Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329 (5) 332-342
  • 68 Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11 (6) 1033-1037
  • 69 Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369 (9569) 1287-1301
  • 70 Sherstha R, McKinley C, Russ P , et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997; 26 (5) 1282-1286
  • 71 Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359 (14) 1477-1485
  • 72 Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic liver disease: experience at a teaching hospital. Am J Gastroenterol 2005; 100 (10) 2212-2217
  • 73 Gigot JF, Jadoul P, Que F , et al. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?. Ann Surg 1997; 225 (3) 286-294
  • 74 Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 2009; 250 (1) 112-118
  • 75 Dixon E, Sutherland FR, Mitchell P, McKinnon G, Nayak V. Cystadenomas of the liver: a spectrum of disease. Can J Surg 2001; 44 (5) 371-376
  • 76 Palacios E, Shannon M, Solomon C, Guzman M. Biliary cystadenoma: ultrasound, CT, and MRI. Gastrointest Radiol 1990; 15 (4) 313-316
  • 77 Marcial MA, Hauser SC, Cibas ES, Braver J. Intrahepatic biliary cystadenoma. Clinical, radiological, and pathological findings. Dig Dis Sci 1986; 31 (8) 884-888
  • 78 Buetow PC, Buck JL, Pantongrag-Brown L , et al. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995; 196 (3) 805-810
  • 79 Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18 (11) 1078-1091
  • 80 Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977; 39 (1) 322-338
  • 81 Florman SS, Slakey DP. Giant biliary cystadenoma: case report and literature review. Am Surg 2001; 67 (8) 727-732
  • 82 Albiin N. MRI of focal liver lesions. Curr Med Imaging Rev 2012; 8 (2) 107-116
  • 83 Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging 2007; 7 (Spec No A): S1-14
  • 84 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12 (8) 509-522
  • 85 van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 2012; 99 (7) 911-916
  • 86 Lewin M, Handra-Luca A, Arrivé L , et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006; 241 (2) 433-440
  • 87 Noels JE, van Aalten SM, van der Windt DJ , et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011; 54 (3) 553-558
  • 88 Kobayashi S, Sakaguchi H, Takatsuka M , et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009; 3 (2) 416-420
  • 89 Ishizawa T, Gumbs AA, Kokudo N, Gayet B. Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 2012; 256 (6) 959-964
  • 90 Toro A, Gagner M, Di Carlo I. Has laparoscopy increased surgical indications for benign tumors of the liver?. Langenbecks Arch Surg 2013; 398 (2) 195-210
  • 91 Lin NC, Nitta H, Wakabayashi G. Laparoscopic major hepatectomy: a systematic literature review and comparison of 3 techniques. Ann Surg 2013; 257 (2) 205-213
  • 92 Lerner SM, Hiatt JR, Salamandra J , et al. Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004; 139 (8) 818-821 , discussion 821–823
  • 93 Vagefi PA, Eilers H, Hiniker A, Freise CE. Liver transplantation for giant hepatic angiomyolipoma. Liver Transpl 2011; 17 (8) 985-986
  • 94 Vagefi PA, Klein I, Gelb B , et al. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg 2011; 15 (1) 209-214
  • 95 Marino IR, Scantlebury VP, Bronsther O, Iwatsuki S, Starzl TE. Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int 1992; 5 (Suppl. 01) S201-S205
  • 96 Lerut J, Ciccarelli O, Rutgers M , et al. Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease. Transpl Int 2005; 18 (5) 513-518
  • 97 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 2011; 9 (7) 547-562 , e1–e4